{"id":3606,"date":"2021-02-19T13:19:54","date_gmt":"2021-02-19T13:19:54","guid":{"rendered":"http:\/\/www.enyopharma.com\/fr\/?p=3606"},"modified":"2021-02-19T13:19:54","modified_gmt":"2021-02-19T13:19:54","slug":"nouvelle-publication-mitochondrial-morphodynamics-alteration-induced-by-influenza-virus-infection-as-a-new-antiviral-strategy","status":"publish","type":"post","link":"https:\/\/www.enyopharma.com\/fr\/nouvelle-publication-mitochondrial-morphodynamics-alteration-induced-by-influenza-virus-infection-as-a-new-antiviral-strategy\/","title":{"rendered":"Nouvelle publication : Mitochondrial morphodynamics alteration induced by influenza virus infection as a new antiviral strategy"},"content":{"rendered":"<p>ENYO Pharma avec l&#8217;\u00e9quipe d&#8217;Etienne Morel poursuit son exploration antivirale de ses compos\u00e9s ciblant les prot\u00e9ines NEET dans le contexte du virus de la grippe. Dans ce nouvel article nous montrons que MITO-C imprime une signature membranaire inverse de celle de la grippe autour de la mitochondrie et de ses sites de contact avec le r\u00e9ticulum endoplasmique. Cet effet permet de potentialiser la production d&#8217;interf\u00e9ron et d&#8217;inhiber la r\u00e9plication du virus. <a href=\"http:\/\/www.enyopharma.com\/fr\/technologie\/publications\/\">Acc\u00e8s \u00e0 la publication<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ENYO Pharma avec l&#8217;\u00e9quipe d&#8217;Etienne Morel poursuit son exploration antivirale de ses compos\u00e9s ciblant les prot\u00e9ines NEET dans le contexte du virus de la grippe. Dans ce nouvel article nous montrons que MITO-C imprime une signature membranaire inverse de celle de la grippe autour de la mitochondrie et de ses sites de contact avec le r\u00e9ticulum endoplasmique. Cet effet permet de potentialiser la production d&#8217;interf\u00e9ron et d&#8217;inhiber la r\u00e9plication du virus. <a href=\"http:\/\/www.enyopharma.com\/fr\/technologie\/publications\/\">Acc\u00e8s \u00e0 la publication<\/a><\/p>\n<p><a class=\"read-more\" href=\"https:\/\/www.enyopharma.com\/fr\/nouvelle-publication-mitochondrial-morphodynamics-alteration-induced-by-influenza-virus-infection-as-a-new-antiviral-strategy\/\">Lire la suite&nbsp;&raquo;<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[21],"tags":[],"class_list":["post-3606","post","type-post","status-publish","format-standard","hentry","category-latest-news-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"editorENYOPharma","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/editorenyopharma\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/www.enyopharma.com\/fr\/category\/latest-news-fr\/\" rel=\"category tag\">Br\u00e8ves<\/a>","rttpg_excerpt":"ENYO Pharma avec l&#8217;\u00e9quipe d&#8217;Etienne Morel poursuit son exploration antivirale de ses compos\u00e9s ciblant les prot\u00e9ines NEET dans le contexte du virus de la grippe. Dans ce nouvel article nous montrons que MITO-C imprime une signature membranaire inverse de celle de la grippe autour de la mitochondrie et de ses sites de contact avec le&hellip;","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3606","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=3606"}],"version-history":[{"count":1,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3606\/revisions"}],"predecessor-version":[{"id":3607,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3606\/revisions\/3607"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=3606"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=3606"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=3606"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}